Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a known or suspected brain tumor (either confirmed or being investigated).
- You have already had treatment (such as radiation or surgery) for a brain tumor, and scans suggest the tumor may have come back — this includes returning spread-from-elsewhere tumors, returning fast-growing brain tumors (high-grade), or returning slower-growing brain tumors (low-grade).
- Alternatively, you have not yet had treatment for a brain tumor and are scheduled for a biopsy or surgery.
- You are older than 3 years of age.
- You are already taking part in another clinical trial, including one using a surgical guiding agent called 5-aminolevulinic acid.
Who may not be able to join:
- You have a known reason why you cannot safely have a PET scan, CT scan, or MRI scan.
- The trial doctors feel you are unlikely to be able to follow the study's procedures and requirements — though please note that sedation or light anesthesia may be offered to participants who have difficulty tolerating the scans (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Javier Villanueva-Meyer, MD, University of California, San Francisco
Phone: (415) 502-1822
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum Intracranial lesion tumor-to-background ratio (TBRmax); Percentage of accurate prediction of presence of tumor (Population 1); Percentage of radiological read responses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.